Skip to content
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact

Pushing the Forefront of
Therapeutic Antibody Discovery

OmniAb® provides our pharmaceutical industry partners access to the most diverse antibody repertoires and cutting-edge screening technologies to enable discovery of next-generation therapeutics.

The advantage of choosing OmniAb for antibody discovery

OmniAb partners enjoy access to the most comprehensive and cutting-edge suite of clinically proven antibody discovery technologies available. We offer validated and proprietary transgenic animals capable of generating high-quality, fully human antibodies to help identify the ideal therapeutic.

Discover our transgenic
animal platforms.

OmnidAb

Heavy Chain-Only Transgenic Chicken

The first and only transgenic chicken host that can generate humanized single-domain antibodies, enabling greater immune recognition of highly conserved antigens and the discovery of more diverse antibody repertoires. These can serve in a variety of applications.

Learn About OmnidAb®
OmnidAb Antibody

What's New
at OmniAb

Read the latest news and press
releases about OmniAb technology.
Read News & Press Releases

Ligand Announces that Janssen has Received Approval from European Commission...

Ligand to Spin-Off its OmniAb Business Through Merger with Avista...

Partner Access Program

Our partners can now experience the advantages of xPloration’s fast processing speed, exceptional hit recovery, unparalleled ease-of-use and reliability in their own laboratories.

Learn About xPloration®
xploration_cart

What's New at OmniAb

Read the latest news and press releases about OmniAb technology.

Read News & Press Releases

Publications & Presentations

Search and browse recent presentations and peer-reviewed publications about OmniAb technology

View Publications

Become an OmniAb partner

See how more than 90 biopharmaceutical companies and research institutions worldwide are using OmniAb technology and capabilities to advance clinical drug development. No other transgenic company serving the marketplace today offers the level of expertise and collaborative approach that we do. OmniAb provides the industry with several transgenic animal species. When you choose to work with us as your therapeutics company, we bring an exceptional amount of depth on our scientific team, meaning you can always expect the best from us.

Partner With Us

Get in Touch

Learn about our antibody discovery services
and find out which could work best for you.

Contact Us

About

  • Team
  • Board of Directors
  • Careers

Partnerships

  • Overview
  • Why Partner with OmniAb?
  • Partner Pipeline
  • Contact Business Development

Technology

  • Overview
  • Antigen Design
  • Antibody Generation
  • Antibody Optimization
  • Ion Channel and Transporter Technology
  • Scientific Publications

OmniAb, Inc.
5980 Horton Street
Suite 600
Emeryville, CA 94608

Contact | Privacy Policy | Disclaimer

© 2025 OmniAb, Inc. All rights reserved.